Literature DB >> 31708208

Hepatopulmonary fusion: A rare variant of congenital diaphragmatic hernia.

Dalya M Ferguson1.   

Abstract

BACKGROUND: Hepatopulmonary fusion (HPF), a rare anomaly associated with right congenital diaphragmatic hernia (CDH), is characterized by a fibrovascular fusion between herniated liver and lung parenchyma. We aimed to clarify patient characteristics, management strategies, and outcomes in HPF.
METHODS: Data on infants with HPF were obtained from the Congenital Diaphragmatic Hernia Registry (CDHR). Patient characteristics, management, and outcomes were compared with the results of a literature review.
RESULTS: Ten cases of HPF were identified in the CDHR. Five patients survived. The median estimated gestational age was 38 weeks (range 36-40). Median birth weight was 2.7 kg (range 2.0-3.8 kg), but non-survivors had a lower median birth weight (2.3 kg vs. 3.5 kg). All patients had at least 1 congenital anomaly in addition to CDH. Operative approach varied, but most surgeons performed only partial separation of the liver and lung (n = 6). The 2 patients who underwent complete separation both ultimately died, 1 due to significant postoperative complications and 1 due to severe pulmonary hypertension with multiple vascular anomalies.
CONCLUSION: Partial separation of liver and lung appears to be the wisest surgical approach in HPF, as complete separation has resulted in catastrophic complications due to frequent underlying vascular anomalies. LEVEL OF EVIDENCE: IV.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case series; Congenital diaphragmatic hernia; Congenital pulmonary venolobar syndrome; Hepatopulmonary fusion; Neonatal

Mesh:

Year:  2019        PMID: 31708208     DOI: 10.1016/j.jpedsurg.2019.09.037

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Right-Sided Congenital Diaphragmatic Hernia Caused by Hepatopulmonary Fusion.

Authors:  Sonal Patel; Jennifer Rael
Journal:  Case Rep Pediatr       Date:  2020-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.